IP Library › Granted Patent US 7,998,379
Granted Patent B2
US 7,998,379 · App. 11/569,286 · Granted Aug 16, 2011

Process for the production of porous moulded articles containing alginate

Assignee: Dr. Suwelack Skin & Health Care AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,998,379
App. No.
11/569,286
Granted
Aug 16, 2011
Kind
B2
Abstract

The invention relates to a process for the production of alginate-containing porous or sponge-like moulded articles, and to the moulded articles obtainable thereby and their use.

Claims (38)

1. A process for the production of freeze-dried porous molded articles comprising:

(a) mixing an aqueous alginate solution with at least one mineral acid until a pH of less than 6 is established,

(b) subsequently adding a component comprising calcium sulfate,

(c) pouring the resulting mixture into a mold and

(d) subsequently freeze-drying the resulting cross-linked alginate-mixture,

wherein the process excludes the addition of foam-stabilizing agents.

2. The process according to claim 1 , wherein the mineral acid is hydrochloric acid.

3. The process according to claim 1 , wherein the aqueous alginate solution is the aqueous solution of an alkali metal alginate.

4. The process according to claim 1 , wherein the component of (b), further comprises carboxymethylcelluose or a salt thereof.

5. The process according to claim 1 , wherein the component of (b) further comprises sodium carboxymethylcellulose.

6. The process according to claim 1 , further comprising after (a), and before (b), adding a complexing agent for calcium.

7. The process according to claim 6 , wherein the complexing agent is a carboxylate of an α-hydroxypolycarboxylic acid.

8. The process according to claim 7 , wherein the complexing agent is a citrate or malate of an α-hydroxypolycarboxylic acid.

9. The process according to claim 1 , further comprising before freeze-drying, adding at least one further component selected from the group consisting of: cosmetic or medical active ingredients; natural or synthetic hydrocolloid-forming polymers; and cosmetic or medical auxiliary substances or additives.

10. The process according to claim 9 , wherein the further component is at least one natural polysaccharide or a modified derivative thereof.

11. The process according to claim 9 , wherein the further component is hyaluronic acid or a salt thereof.

12. The process according to claim 9 , wherein the further component is urea or glycerin.

13. The process according to claim 9 , wherein the further component is squalane, jojoba oil or triglycerides of natural fatty acids.

14. The process according to claim 9 , wherein the further component is a vitamin.

15. The process according to claim 9 , wherein the further component is an agent for the treatment of skin diseases or an antibacterial agent.

16. The process according to claim 1 , wherein the addition of a salt of a polyvalent metal ion with a polydentate complexing anion is excluded.

17. The process according to claim 1 , further comprising cutting the freeze-dried molded article into layer form.

18. The process according to claim 1 , further comprising compressing the freeze-dried molded article into compressed form.

19. The process according to claim 18 , wherein the compressed molded article is in the form of an orally administrable agent.

20. The process according to claim 18 , wherein the compressed molded article is the form of an orally administrable satiating product.

21. The process according to claim 18 , wherein the compressed molded article is in the form of an orally administrable agent for the controlled release of an active ingredient.

22. The process according to claim 1 , wherein the pH value of the alginate solution, established by the mineral acid, is less than 5.

23. The process according to claim 1 , wherein the concentration of the alginate in the aqueous solution is less than 2% (w/w) and the pH value of the alginate solution, established by the mineral acid, is less than 5.

24. The process according to claim 1 , wherein the mixture is poured in a layer thickness of from 1 to 50 centimeters before freeze-drying.

25. The process according to claim 24 , wherein the resulting freeze-dried molded articles are cut into layers of 0.5 to 20 mm thickness.

26. The process according to claim 1 , wherein the concentration of the alginate in the aqueous solution is less than 2% (w/w) and the pH value of the alginate solution, established by the mineral acid, is less than 5, and wherein the resulting mixture is poured in a layer thickness of from 1 to 50 centimeters before freeze-drying.

27. A process for the production of freeze-dried porous molded articles comprising:

(a) mixing an aqueous alginate solution with a concentration of less than 2% (w/w) with at least one mineral acid until a pH of less than 5 is established,

(b) subsequently adding calcium sulfate,

(c) pouring the resulting mixture in a layer thickness of at least one centimeter up to 50 centimeter thickness into a mold,

(d) subsequently freeze-drying the resulting cross-linked alginate-mixture, and

(e) cutting the resulting freeze-dried molded articles into layers of 0.5 to 20 mm thickness,

wherein the process excludes the addition of foam-stabilizing agents.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2006
From: MALESSA, RALF
To: DR. SUWELACK SKIN & HEALTH CARE AG
Reel/Frame 018689/0144 →
Priority Claims (1)
DE 10 2004 025 495 · May 21, 2004 · national
Continuity (1)
Related Publication 20070218285A1 · Sep 20, 2007